Ginkgo (DNA) CEO Jason R. Kelly Receives RSU Awards

What Happened

• Jason R. Kelly, Chief Executive Officer and Founder of Ginkgo Bioworks Holdings, received two restricted stock unit (RSU) awards on July 28, 2026 totaling 383,725 RSUs (74,258 RSUs + 309,467 RSUs). The awards are derivative grants (no exercise price reported). Each RSU represents a contingent right to one share of Class A common stock.

Key Details

• Transaction date: July 28, 2026; filing date: July 30, 2026 (filed within the normal 2-business-day window).
• Awards: 74,258 RSUs and 309,467 RSUs; total = 383,725 RSUs. Price: N/A (derivative grant).
• Vesting: one grant vests 75% on Oct 16, 2026 and 25% on Jan 21, 2027; the other vests in equal quarterly installments over the next 12 quarters with first vesting on Oct 16, 2026.
• Shares owned after the transaction are not reported on this Form 4.
• Footnote: each RSU converts to one share upon vesting (no immediate share issuance). These are compensation awards, not open-market purchases or sales.

Context

• RSU grants are compensation-driven and become actual shares only as they vest; they do not represent an immediate buy or sale of stock. Such awards are common for executives and should be viewed as part of pay/retention programs rather than a direct bullish or bearish trade signal.